U.S. clinical trials with Takeda acellular pertussis vaccine.
Stout
M G
MG
Lederle Laboratories, Pearl River, New York 10965.
D000367:Age Factors; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D001886:Bordetella pertussis / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003448:Crying; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000009:adverse effects / Q000302:isolation & purification / Q000627:therapeutic use; D004890:Erythema / Q000209:etiology; D005334:Fever / Q000209:etiology; D006801:Humans; D007223:Infant; D007508:Irritable Mood; D010567:Pertussis Vaccine / Q000009:adverse effects / Q000302:isolation & purification / Q000627:therapeutic use*; D014481:United States
D000907:Antibodies, Bacterial; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D010567:Pertussis Vaccine